Filter
949
Filtered Results: 949
Text search:
Medicines
Trade
and
Production
Featured
Recommendations
71
New Publications
231
Language
Document type
No document type
466
Studies & Reports
222
Guidelines
102
Strategic & Response Plan
76
Manuals
45
Training Material
15
Fact sheets
11
Situation Updates
9
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
Global
62
Kenya
29
India
26
Sierra Leone
22
Western and Central Europe
21
South Africa
18
Nigeria
17
Ghana
17
Myanmar / Burma
17
Africa
17
Liberia
16
Ethiopia
16
Uganda
14
Philippines
14
Zambia
13
Syria
13
Nepal
11
Tanzania
11
Ukraine
11
Congo, Democratic Republic of
10
Zimbabwe
10
Rwanda
10
South–East Asia Region
10
Latin America and the Carribbean
9
South Sudan
8
Malawi
8
Guinea
6
Thailand
6
Bangladesh
6
Mozambique
6
Madagascar
6
Asia
6
USA
5
Cameroon
5
Cambodia
5
Eastern Europe
5
Laos
5
Senegal
4
Indonesia
4
Sudan
4
Namibia
4
Eswatini/ Swaziland
4
Lesotho
4
East and Southern Africa
4
West and Central Africa
4
Middle East and North Africa
4
Jordan
3
Germany
3
North Macedonia
3
Yemen
3
Eastern Europe and Central Asia
3
Vietnam
3
Haiti
2
Pakistan
2
Lebanon
2
Central African Republic
2
Brazil
2
Western Pacific Region
2
Venezuela
2
Timor Leste/ East Timor
2
Tajikistan
2
Russia
2
Moldova
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
Mauritius
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Somalia
1
Afghanistan
1
Egypt
1
Chad
1
China
1
Papua New Guinea
1
Benin
1
Argentina
1
Serbia
1
Hungary
1
Colombia
1
Botswana
1
Libya
1
Angola
1
Mexico
1
Sri Lanka
1
Paraguay
1
Albania
1
Estonia
1
Georgia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Norway
1
Portugal
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
330
Public Health
63
Clinical Guidelines
48
Key Resources
47
Women & Child Health
20
Pharmacy & Technologies
13
Capacity Building
8
Toolboxes
COVID-19
90
AMR
86
Planetary Health
76
Mental Health
71
HIV
40
Conflict
35
Pharmacy
35
Global Health Education
32
Rapid Response
29
TB
26
Ebola
24
Health Financing Toolbox
19
Specific Hazards
18
NCDs
16
Natural Hazards
14
NTDs
14
Caregiver
13
Disability
11
Refugee
9
Cholera
5
Polio
2
Zika
1
Health Financing
1
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals ... negatively impacted on healthcare systems’ ability to provide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure impo...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation ... Registration (MER) of the East African Community Medicine Regulatory Harmonization (EAC MRH) Project. The group relied on their experiences and knowledge on medicines registration requirements of their individual Countries. World Health Organization (WHO) and the International Conference on Harmonization of Technical Requirements of Medicines for Human Use (ICH) and other available literature.
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human ... (WHO CIA List). These guidelines aim primarily to help preserve the effectiveness of medically important antimicrobials, particularly those antimicrobials judged to be critically important to human medicine and also help preserve the effectiveness of antimicrobials for veterinary medicine, in direct support of the WHO global action plan on antimicrobial resistance
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right ... for a range of conditions
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases ... veterinary medicine formed a core group at the organizational meeting of GARP in Kathmandu, Nepal in July 2016. In the meeting, this core group was expanded to include other members from different sectors with the selection of the Chair and co-chairs. These were asked to serve on a voluntary basis, in their own individual capacities, with no personal gains, or gains to the institutions to which they are affiliated. The first phase of GARP took place from 2009 to 2011 and involved four countries: India, Kenya, South Africa and Vietnam. Phase one culminated in the 1st Global Forum on Bacterial Infections, held in October 2011 in New Delhi, India. In 2012, phase two of GARP was initiated with the addition of working groups in Mozambique, Tanzania, Nepal and Uganda. Phase three has added Bangladesh, Lao PDR, Nigeria, Pakistan and Zimbabwe to the network to date.
Healthy people, healthy animals and a healthy environment worldwide with the One Health approach.
The COVID-19 pandemic has drastically demonstrated just how close the link is between humans, animals, and... the environment, and has highlighted and aggravated existing challenges. The destruction of natural habitats and displacement of species, trade in wild animals, resource-intensive lifestyles and conditions, non-sustainable food systems and, in particular, industrial agriculture and intensive livestock farming are the causes of the emergence of zoonoses as well as numerous other communicable and non-communicable, chronic diseases.
The One Health approach focuses precisely on such interaction between humans, animals, and the environment.
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resi...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with th...
Governments have dedicated a pivotal role to the private sector in the implementation and financing of the 2030 Agenda and the SDGs. This has pushed a turn towards the private sector, the promotion ...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental ... ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the potential to impact overall global development. It is important, therefore, to elevate AMR beyond health as part of a larger development agenda in the context of the Sustainable Development Goals (SDGs). This report provides in-depth technical discussions in areas that have direct implications to the containment of AMR as a development agenda. The report is organized in five chapters which served as the technical background documents for the Biregional Technical Consultation on AMR in Asia, 14-15 April 2016. More information from the meeting is available in the WHO Meeting Report: Biregional Technical Consultation on Antimicrobial Resistance in Asia. The meeting was the first time senior officials from the Ministry of Health and Ministry of Agriculture across Asia came together to tackle AMR
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe ... that are quality-assured, used in a responsible way, and accessible to all who need them.
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production ... inadequate waste disposal in the production of antimicrobials in China and India, which supplies most of the antimicrobials consumed in Europe. In a briefing detailing the pollution, the EPHA urges major purchasers of antibiotics to blacklist irresponsible pharmaceutical companies, demand that the industry clean up its supply chain, introduce greater transparency on the origin of antibiotics, and review and revise procurement policies from an ethics perspective.
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic ne...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and...
- The Role of Plant Nutrition in Supporting Food Security
- Micronutrient Malnutrition: Causes, Prevalence, Consequences and Interventions
- Fertilizer Application and Nutraceutical Content in
He...
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield ... numbers needed to screen (NNS) by country and WHO-reported TB burden, (ii) the possible impact of screening thresholds on sensitivity, and (iii) the value of WHO-estimated TB burden to improve the prediction accuracy of screening yield.
With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, ... what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographical areas, but this situation has become more fluid due to a host of ills, including climate change, intensive farming, dams, irrigation, deforestation, population movements, rapid unplanned urbanization, and phenomenal increases in international travel and trade. The control of vector-borne diseases can make a major contribution to poverty reduction, as it precisely targets the poor
This report provides an update on the level of poverty based on 2013/14 Integrated Household Living Conditions Survey (EICV4) focusing on poverty as measured in consumption terms. The report also highlights other trend dimensions of living conditions captured in other surveys that complement ... provide a holistic understanding of poverty and living conditions.
Rwanda’s economy has been growing steadily at about 8% since 2001 with GDP per capita more than tripling from US$ 211 in 2001 to US$ 718 in 2014. Food crop production growth was more than twice that of population growth between 2007 and 2014.
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six ty...
